Evotec repays 50 per cent of EUR140m acquisition loan
Evotec AG has completed the repayment of 50 per cent of its EUR140 million debt bridge facility within the first year of it being granted for the acquisition of Aptuit in 2017. Effective August 2017, Evotec acquired Aptuit, a partner research organisation for integrated outsourced drug discovery and development, for

